Subscribe to Newsletter

Bioprocessing - Upstream & Downstream

Manufacture Bioprocessing - Upstream & Downstream

Less Patience, More Patients

| 4 min read

Sitting Down With Dick Sundh, General Manager, Kite Pharma

Manufacture Bioprocessing - Upstream & Downstream

Getting More from Your Buffer Management Strategy

| Sponsored by Asahi Kasei Bioprocess | 7 min read

We delve into the story behind Lonza’s collaboration with Asahi Kasei Bioprocess America.

Manufacture Bioprocessing - Upstream & Downstream

Planes, Trains, and Autologous Therapies

| Sumukhi Sreevatsan | 3 min read

The potential of the cell and gene therapies sector depends – partially – on the expertise of the transport and logistics partners that complement it.

Manufacture Bioprocessing - Upstream & Downstream

The Viral Frontier

| Natalia Elizalde | 3 min read

How can companies beat the bottlenecks in viral vector manufacturing?

Manufacture Bioprocessing - Upstream & Downstream

The Future of Biopharma Analytics

| Stephanie Vine | 6 min read

What lies ahead for biopharma manufacturers when it comes to downstream analytical tech?

Manufacture Advanced Medicine

The Mycoplasma Issue

| Marwan Alsarraj | 5 min read

While contamination issues continue to limit the potential of gene therapy, scientists can no longer afford to ignore the best detection methods.

Business & Regulation Profession

Celebrating People with Power

| Stephanie Vine

Who are the most influential and inspirational people in drug development and manufacturing? Nominations for the Power List 2024 are now open!

Manufacture Bioprocessing - Upstream & Downstream

Creating for Tomorrow

| Sponsored by Asahi Kasei | 7 min read

We interview Clayton Weber, Systems Engineering Lead/ Sustainability Lead at Asahi Kasei Bioprocess

Manufacture Advanced Medicine

Scaling Gene Therapy Challenges – Together

| Catherine Buchere, Kathrin Teschner | 7 min read

Understanding AAV production and characterization processes – and establishing strategies for success.

Discovery & Development Drug Discovery

Meet the New Wave of Therapeutic Antibodies

| Sponsored by Bio-Rad Laboratories | 6 min read

How increased biological understanding and advanced technology are generating new antibody-based modalities with exciting potential.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register